# Adding Magnesium Sulfate to Bupivacaine for Ilioinguinal and Iliohypogastric Nerve Block

> **NCT05158647** · PHASE2 · COMPLETED · sponsor: **Abdelrady S Ibrahim, MD** · enrollment: 90 (actual)

## Conditions studied

- Magnesium Sulfate Causing Adverse Effects in Therapeutic Use

## Interventions

- **OTHER:** normal saline
- **DRUG:** MgSo4

## Key facts

- **NCT ID:** NCT05158647
- **Lead sponsor:** Abdelrady S Ibrahim, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-12
- **Primary completion:** 2020-02-07
- **Final completion:** 2020-04-21
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2021-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05158647

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05158647, "Adding Magnesium Sulfate to Bupivacaine for Ilioinguinal and Iliohypogastric Nerve Block". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05158647. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*